VSTM logo

VSTM
Verastem Inc

24,083
Mkt Cap
$502.38M
Volume
1.28M
52W High
$11.25
52W Low
$4.01
PE Ratio
-1.57
VSTM Fundamentals
Price
$6.67
Prev Close
$6.28
Open
$6.36
50D MA
$7.94
Beta
1.34
Avg. Volume
2.06M
EPS (Annual)
-$3.66
P/B
-28.68
Rev/Employee
$128,205.13
Loading...
Loading...
News
all
press releases
FY2025 EPS Estimates for Verastem Increased by HC Wainwright
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for Verastem in a note issued to investors on Thursday, February...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Verastem, Inc. (NASDAQ:VSTM - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten research firms that are covering the company, Marketbeat.com reports...
MarketBeat·1d ago
News Placeholder
HC Wainwright Forecasts Verastem FY2025 Earnings
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Equities research analysts at HC Wainwright issued their FY2025 EPS estimates for shares of Verastem in a report released on Wednesday, February 4th. HC...
MarketBeat·3d ago
News Placeholder
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
VSTM shares rise nearly 8% after the release of preliminary fourth-quarter 2025 and full-year 2025 sales numbers, driven by Avmapki Fakzynja Co-pack.
Zacks·4d ago
News Placeholder
HC Wainwright Estimates Verastem FY2030 Earnings
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Research analysts at HC Wainwright issued their FY2030 earnings per share estimates for shares of Verastem in a research note issued on Wednesday...
MarketBeat·4d ago
News Placeholder
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors $668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors PR Newswire VANCOUVER, BC, Jan. 30, 2026 Issued on behalf of...
PR Newswire·10d ago
News Placeholder
Verastem (NASDAQ:VSTM) CFO Sells $36,079.24 in Stock
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) CFO Daniel Calkins sold 5,039 shares of Verastem stock in a transaction on Monday, January 12th. The stock was sold at an average price of $7.16, for a...
MarketBeat·25d ago
News Placeholder
Daniel Calkins Sells 5,039 Shares of Verastem (NASDAQ:VSTM) Stock
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) CFO Daniel Calkins sold 5,039 shares of the business's stock in a transaction on Monday, January 12th. The shares were sold at an average price of...
MarketBeat·26d ago
News Placeholder
Insider Selling: Verastem (NASDAQ:VSTM) CEO Sells 10,321 Shares of Stock
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) CEO Dan Paterson sold 10,321 shares of the firm's stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $7.16...
MarketBeat·26d ago
News Placeholder
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of stock options to...
Business Wire·28d ago
<
1
2
...
>

Latest VSTM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.